rs104886089

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_033380.3(COL4A5):​c.1033-15delT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00413 in 1,093,951 control chromosomes in the GnomAD database, including 15 homozygotes. There are 1,338 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.0045 ( 4 hom., 129 hem., cov: 21)
Exomes 𝑓: 0.0041 ( 11 hom. 1209 hem. )

Consequence

COL4A5
NM_033380.3 intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.409

Publications

0 publications found
Variant links:
Genes affected
COL4A5 (HGNC:2207): (collagen type IV alpha 5 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Mutations in this gene are associated with X-linked Alport syndrome, also known as hereditary nephritis. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Aug 2010]
COL4A5 Gene-Disease associations (from GenCC):
  • Alport syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen, G2P
  • X-linked Alport syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Genomics England PanelApp, Myriad Women’s Health, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant X-108586590-AT-A is Benign according to our data. Variant chrX-108586590-AT-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 24358.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00446 (474/106363) while in subpopulation NFE AF = 0.00719 (367/51075). AF 95% confidence interval is 0.00658. There are 4 homozygotes in GnomAd4. There are 129 alleles in the male GnomAd4 subpopulation. Median coverage is 21. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A5NM_033380.3 linkc.1033-15delT intron_variant Intron 18 of 52 ENST00000328300.11 NP_203699.1 P29400-2Q49AM6A7MBN3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A5ENST00000328300.11 linkc.1033-24delT intron_variant Intron 18 of 52 1 NM_033380.3 ENSP00000331902.7 P29400-2
COL4A5ENST00000483338.1 linkc.-144-24delT intron_variant Intron 2 of 19 1 ENSP00000495685.1 Q49AM6
COL4A5ENST00000361603.7 linkc.1033-24delT intron_variant Intron 18 of 50 2 ENSP00000354505.2 P29400-1

Frequencies

GnomAD3 genomes
AF:
0.00446
AC:
474
AN:
106330
Hom.:
4
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.00113
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00111
Gnomad ASJ
AF:
0.00670
Gnomad EAS
AF:
0.000291
Gnomad SAS
AF:
0.00249
Gnomad FIN
AF:
0.00694
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00718
Gnomad OTH
AF:
0.00140
GnomAD2 exomes
AF:
0.00681
AC:
911
AN:
133794
AF XY:
0.00698
show subpopulations
Gnomad AFR exome
AF:
0.00206
Gnomad AMR exome
AF:
0.00291
Gnomad ASJ exome
AF:
0.00487
Gnomad EAS exome
AF:
0.00117
Gnomad FIN exome
AF:
0.0132
Gnomad NFE exome
AF:
0.00854
Gnomad OTH exome
AF:
0.0130
GnomAD4 exome
AF:
0.00410
AC:
4046
AN:
987588
Hom.:
11
Cov.:
26
AF XY:
0.00383
AC XY:
1209
AN XY:
315924
show subpopulations
African (AFR)
AF:
0.00119
AC:
28
AN:
23479
American (AMR)
AF:
0.00228
AC:
73
AN:
32059
Ashkenazi Jewish (ASJ)
AF:
0.00323
AC:
56
AN:
17340
East Asian (EAS)
AF:
0.000328
AC:
9
AN:
27444
South Asian (SAS)
AF:
0.00351
AC:
169
AN:
48211
European-Finnish (FIN)
AF:
0.0113
AC:
427
AN:
37696
Middle Eastern (MID)
AF:
0.000806
AC:
3
AN:
3722
European-Non Finnish (NFE)
AF:
0.00411
AC:
3109
AN:
756324
Other (OTH)
AF:
0.00416
AC:
172
AN:
41313
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
130
259
389
518
648
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00446
AC:
474
AN:
106363
Hom.:
4
Cov.:
21
AF XY:
0.00428
AC XY:
129
AN XY:
30135
show subpopulations
African (AFR)
AF:
0.00112
AC:
33
AN:
29359
American (AMR)
AF:
0.00111
AC:
11
AN:
9901
Ashkenazi Jewish (ASJ)
AF:
0.00670
AC:
17
AN:
2539
East Asian (EAS)
AF:
0.000292
AC:
1
AN:
3426
South Asian (SAS)
AF:
0.00250
AC:
6
AN:
2404
European-Finnish (FIN)
AF:
0.00694
AC:
37
AN:
5330
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
208
European-Non Finnish (NFE)
AF:
0.00719
AC:
367
AN:
51075
Other (OTH)
AF:
0.00138
AC:
2
AN:
1448
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
17
34
51
68
85
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00880
Hom.:
0
Bravo
AF:
0.00288
Asia WGS
AF:
0.00518
AC:
13
AN:
2521

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Feb 17, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: COL4A5 c.1033-15delT alters a non-conserved nucleotide within a poly-T region located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.0068 in 133794 control chromosomes in the gnomAD database, including 5 homozygotes. The observed variant frequency is approximately 1.5-fold of the estimated maximal expected allele frequency for a pathogenic variant in COL4A5 causing Alport Syndrome 1, X-Linked Recessive phenotype (0.0046), strongly suggesting that the variant is benign. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. -

not provided Benign:1
Feb 26, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

X-linked Alport syndrome Benign:1
Dec 13, 2018
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.41
La Branchor
0.71
BranchPoint Hunter
6.0
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs104886089; hg19: chrX-107829820; COSMIC: COSV60372614; API